Compassionate Care Research Group, Inc., at Compassionate Cancer Care Medical Group, Inc.

Fountain Valley, California 92708

0 studies enrolling now · 5 studies all time

What they study most

BRAF V600E-mutant Metastatic Colorectal Cancer, Breast Cancer, Cachexia; Cancer, Carcinoma, Non-Small-Cell Lung, ErbB Receptors, Follicular Lymphoma, Non Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed
• A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer — Completed
• Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older — Completed
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed